Apoglyx
Lund
About Apoglyx
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $697.1K
- Last round: Series Unknown (Oct 2021)
- Website: apoglyx.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/apoglyx-191097 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.